Biological Effects of Quercetin in COPD Phase II (polyphenols)
view all Clinical Trials
Overview
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.